Hepatic drug metabolism and gut microbiome
This chapter focuses on intestinal microbiota and its effect on drug metabolism. Here, we discussed about different drugs which are metabolized either by some enzymes or gut microbiota and their mechanism. Nowadays, consuming drugs without a doctor's prescription is common. This chapter will ma...
Saved in:
| Published in | Progress in molecular biology and translational science Vol. 191; no. 1; pp. 207 - 228 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Inc
2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | This chapter focuses on intestinal microbiota and its effect on drug metabolism. Here, we discussed about different drugs which are metabolized either by some enzymes or gut microbiota and their mechanism. Nowadays, consuming drugs without a doctor's prescription is common. This chapter will make people aware about its negative consequences and how it is related to gut microbiota dysbiosis. Intestinal disorders like inflammatory bowel disease (IBD), colorectal cancer (CRC) and metabolic disorders such as obesity and type 2 diabetes mellitus (T2D) are found to be affected with gut microbiota dysbiosis. To address this issue, we discussed a variety of strategies such as fecal microbiota transplantation (FMT), probiotics and antibiotic stewardship programs which are commonly used to tackle this problem. |
|---|---|
| AbstractList | This chapter focuses on intestinal microbiota and its effect on drug metabolism. Here, we discussed about different drugs which are metabolized either by some enzymes or gut microbiota and their mechanism. Nowadays, consuming drugs without a doctor's prescription is common. This chapter will make people aware about its negative consequences and how it is related to gut microbiota dysbiosis. Intestinal disorders like inflammatory bowel disease (IBD), colorectal cancer (CRC) and metabolic disorders such as obesity and type 2 diabetes mellitus (T2D) are found to be affected with gut microbiota dysbiosis. To address this issue, we discussed a variety of strategies such as fecal microbiota transplantation (FMT), probiotics and antibiotic stewardship programs which are commonly used to tackle this problem. This chapter focuses on intestinal microbiota and its effect on drug metabolism. Here, we discussed about different drugs which are metabolized either by some enzymes or gut microbiota and their mechanism. Nowadays, consuming drugs without a doctor's prescription is common. This chapter will make people aware about its negative consequences and how it is related to gut microbiota dysbiosis. Intestinal disorders like inflammatory bowel disease (IBD), colorectal cancer (CRC) and metabolic disorders such as obesity and type 2 diabetes mellitus (T2D) are found to be affected with gut microbiota dysbiosis. To address this issue, we discussed a variety of strategies such as fecal microbiota transplantation (FMT), probiotics and antibiotic stewardship programs which are commonly used to tackle this problem.This chapter focuses on intestinal microbiota and its effect on drug metabolism. Here, we discussed about different drugs which are metabolized either by some enzymes or gut microbiota and their mechanism. Nowadays, consuming drugs without a doctor's prescription is common. This chapter will make people aware about its negative consequences and how it is related to gut microbiota dysbiosis. Intestinal disorders like inflammatory bowel disease (IBD), colorectal cancer (CRC) and metabolic disorders such as obesity and type 2 diabetes mellitus (T2D) are found to be affected with gut microbiota dysbiosis. To address this issue, we discussed a variety of strategies such as fecal microbiota transplantation (FMT), probiotics and antibiotic stewardship programs which are commonly used to tackle this problem. |
| Author | Mehrotra, Tanshi Maulik, Subir Kumar |
| Author_xml | – sequence: 1 givenname: Tanshi surname: Mehrotra fullname: Mehrotra, Tanshi organization: Translational Health Science and Technology Institute, Faridabad, Haryana, India – sequence: 2 givenname: Subir Kumar surname: Maulik fullname: Maulik, Subir Kumar email: skmaulik@gmail.com organization: Indian Council Of Medical Research, New Delhi, India |
| BookMark | eNotkM1OwzAQhC1UJNrCG3DIESElrGMndi9IqAKKVIkLnC3_rCujJC6xw_MTWk47h9HM7LciiyEOSMgthYoCbR9Mqo69yamqoa4rEBVAc0GWVApZgqR8cdKipFSwK7JK6QugbSmTS3K_w6POwRZunA5Fj1mb2IXUF3pwxWHKRR_sGE2IPV6TS6-7hDf_d00-X54_trty__76tn3alzjH59Jw76VwKNzcSRtuYONqrz13glsKzG64aBsvjBONl9B47l1jmPXMMyq9Zmtyd849jvF7wpRVH5LFrtMDximpWtSi5fOrcrY-nq047_kJOKpkAw4WXRjRZuViUBTUHyRlkjpBUn-QFAg1Q2K_jUJexw |
| ContentType | Journal Article |
| Copyright | 2022 Elsevier Inc. Copyright © 2022 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2022 Elsevier Inc. – notice: Copyright © 2022 Elsevier Inc. All rights reserved. |
| DBID | 7X8 |
| DOI | 10.1016/bs.pmbts.2022.07.005 |
| DatabaseName | MEDLINE - Academic |
| DatabaseTitle | MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1878-0814 |
| EndPage | 228 |
| ExternalDocumentID | S1877117322001004 |
| GroupedDBID | --- -~X 0R~ 53G 8N7 8NA 8NF AAAAS AALRI AAXUO ABGWT ABMAC ABQQC ACGFO ACGFS ACXMD ADVLN ADXHL AENEX AFOST AFTJW AGAMA AHDLI AHMUE AKRWK ALMA_UNASSIGNED_HOLDINGS ALOFI ASPBG AVWKF AZFZN F5P FDB HZ~ MVM O9- SBF SDK SES SHL YNT 7X8 |
| ID | FETCH-LOGICAL-e173t-b4ff87de7d187154b09d2faf4d74c103c94765f7bd75f805f4fd5b3cf3f318fa3 |
| ISSN | 1877-1173 1878-0814 |
| IngestDate | Thu Jul 10 23:57:51 EDT 2025 Sat Aug 23 17:12:09 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Keystone species Hepatic drug metabolism Keystone species associated with drug metabolism Infectious diseases Intestinal disorders Intestinal microbiota Drug metabolism pathways Metabolic disorders Gut microbiota dysbiosis |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-e173t-b4ff87de7d187154b09d2faf4d74c103c94765f7bd75f805f4fd5b3cf3f318fa3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PQID | 2727642028 |
| PQPubID | 23479 |
| PageCount | 22 |
| ParticipantIDs | proquest_miscellaneous_2727642028 elsevier_sciencedirect_doi_10_1016_bs_pmbts_2022_07_005 |
| PublicationCentury | 2000 |
| PublicationDate | 2022 20220101 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – year: 2022 text: 2022 |
| PublicationDecade | 2020 |
| PublicationTitle | Progress in molecular biology and translational science |
| PublicationYear | 2022 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Antushevich (bb0080) 2020; 503 Almazroo, Miah, Venkataramanan (bb0075) 2017; 21 Albhaisi, Bajaj, Sanyal (bb0055) 2020; 318 Gingell, Bridges, Williams (bb0255) 1971; 1 Rothschild, Weissbrod, Barkan (bb0375) 2018; 555 Robert, Rivory (bb0250) 1998; 1998 Li, He, Jia (bb0205) 2016; 12 Haiser, Seim, Balskus, Turnbaugh (bb0220) 2014; 5 Wilson, Nicholson (bb0175) 2016; 179 Swanson (bb0200) 2015; 43 Gorski, Hall, Becker, Affrime, Cutler, Haehner-Daniels (bb0170) 2000; 67 Gurung, Li, You (bb0120) 2020; 51 Rinninella, Raoul, Cintoni (bb0090) 2019; 7 Selwyn, Cheng, Klaassen, Cui (bb0295) 2016; 44 Amabebe, Robert, Agbalalah, Orubu (bb0110) 2020; 123 Sokol, Seksik, Furet (bb0105) 2009; 15 Wadworth, Fitton (bb0260) 1991; 41 Elkahwaji, Robin, Berson (bb0165) 1999; 57 Hall, Tolonen, Xavier (bb0370) 2017; 18 (accessed 1.15.22). Cammarota, Ianiro, Tilg (bb0430) 2017; 66 Sousa, Paterson, Moore, Carlsson, Abrahamsson, Basit (bb0190) 2008; 363 CDC (bb0415) 2021 Shogbesan, Poudel, Victor (bb0445) 2018; 2018 Antimicrobial resistance [WWW Document], n.d. URL Suzuki, Worobey (bb0325) 2014; 10 Phang-Lyn, Llerena (bb0040) 2021 Nelson (bb0140) 2009; 4 Benedetti, Whomsley, Poggesi (bb0025) 2009; 41 McDonnell, Gilkes, Ashworth (bb0405) 2021; 13 Nakayama, Kinouchi, Kataoka, Akimoto, Matsuda, Ohnishi (bb0240) 1997; 7 Scanlan, Marchesi (bb0130) 2008; 2 Niehues, Hensel (bb0230) 2009; 61 PubChem, n.d. Chloramphenicol [WWW Document]. URL Yatsunenko, Rey, Manary (bb0330) 2012; 486 URL Huffnagle, Noverr (bb0135) 2013; 21 Kelly, Ihunnah, Fischer (bb0450) 2014; 109 Ronis (bb0155) 2016; 48 Gupta, Paul, Dutta (bb0320) 2017; 8 Shetty (bb0345) 2018 (accessed 1.23.22). Jandhyala, Talukdar, Subramanyam, Vuyyuru, Sasikala, Reddy (bb0085) 2015; 21 Genome-Wide Association Studies Fact Sheet [WWW Document], n.d. Dwiyanto, Ayub, Lee, Foo, Chong, Rahman (bb0335) 2021; 7 Lucchetti, Kaminska, Oluwasegun, Mosig, Wilmes (bb0060) 2021; 18 Sun, Chen, Shen (bb0045) 2019; 27 Yang, Yao, Cheng (bb0365) 2020; 11 Ferranti, Dunbar, Dunlop, Corwin (bb0010) 2014; 29 O'Toole, Cooney (bb0455) 2008; 2008 Bloemendaal, Szopinska-Tokov, Belzer (bb0460) 2021; 11 Kho, Lal (bb0015) 2018; 9 Cammarota, Ianiro, Gasbarrini (bb0425) 2014; 48 Dadgostar (bb0470) 2019; 12 Elkington, Floch, Conn (bb0270) 1969; 281 Jie, Xia, Zhong (bb0125) 2017; 8 Liu, Tran, Rhoads (bb0465) 2018; 58 Takeno, Sakai (bb0265) 1991; 44 Javdan, Lopez, Chankhamjon (bb0030) 2020; 181 Nowak, Hedenstierna, Ursing, Lidman, Nowak (bb0435) 2019; 2019 Wilson, Nicholson (bb0180) 2017; 179 Zemanová, Lněničková, Vavrečková (bb0235) 2021; 16 Tomova, Bukovsky, Rembert (bb0300) 2019; 6 Rice (bb0475) 2018; 102 (accessed 1.10.22). Gilbert, Blaser, Caporaso, Jansson, Lynch, Knight (bb0020) 2018; 24 Zhang, Chen (bb0400) 2019; 132 Sheweita (bb0050) 2000; 1 (accessed 1.22.22). Youngster, Mahabamunuge, Systrom (bb0440) 2016; 14 Cancer [WWW Document], 2021 URL Giacomini, Huang, Tweedie (bb0150) 2010; 9 Collins, Patterson (bb0280) 2020; 10 Aleksunes, Klaassen (bb0290) 2012; 40 Sender, Fuchs, Milo (bb0185) 2016; 164 Charles, Rivory, Brown, Liddle, Clarke, Robertson (bb0160) 2006; 12 Peppercorn, Goldman (bb0215) 1972; 181 Zimmermann, Zimmermann-Kogadeeva, Wegmann, Goodman (bb0285) 2019; 570 Zhao, Hu, Chen (bb0210) 2020; 15 Tsunoda, Gonzales, Jarmusch, Momper, Ma (bb0245) 2021; 60 Dąbrowska, Witkiewicz (bb0355) 2016; 7 Turnbaugh, Hamady, Yatsunenko (bb0360) 2009; 457 WHO 2021 New report calls for urgent action to avert antimicrobial resistance crisis [WWW Document], URL https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis (accessed 1.15.22). Sharma, Tripathi (bb0115) 2019; 63 Achour, Barber, Rostami-Hodjegan (bb0145) 2014; 42 Smith, Easson, Lyle (bb0305) 2019; 14 WHO (bb0390) 2019; 1 Crouwel, Buiter, de Boer (bb0035) 2021; 15 Fan, Jin, Chen, Ma, Zhang (bb0100) 2021; 102 Tavalire, Christie, Leve, Ting, Cresko, Bohannan (bb0380) 2021; 12 Huang, Lai, Du, Xu, Ruan, Hu (bb0315) 2019; 10 Monda, Villano, Messina (bb0310) 2017; 2017 Banerjee, Schlaeppi, van der Heijden (bb0225) 2018; 16 Borren, Ghadermarzi, Hutfless, Ananthakrishnan (bb0420) 2017; 12 Monaghan, Sloan, Stockdale (bb0340) 2020; 12 Zhang, Luo, Shi, Fan, Ji (bb0410) 2012; 107 Martignoni, Groothuis, de Kanter (bb0065) 2006; 2 Jourova, Anzenbacher, Anzenbacherova (bb0275) 2016; 160 Nebert, Gonzalez (bb0070) 1987; 56 |
| References_xml | – volume: 27 start-page: 1146 year: 2019 end-page: 1156 ident: bb0045 article-title: Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice publication-title: Saudi Pharm J – reference: (accessed 1.10.22). – volume: 67 start-page: 32 year: 2000 end-page: 43 ident: bb0170 article-title: In vivo effects of interleukin-10 on human cytochrome P450 activity publication-title: Clin Pharmacol Ther – volume: 181 start-page: 555 year: 1972 end-page: 562 ident: bb0215 article-title: The Role of Intestinal Bacteria in the Metabolism of Salicylazosulfapyridine publication-title: J Pharmacol Exp Ther – volume: 57 start-page: 951 year: 1999 end-page: 954 ident: bb0165 article-title: Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy publication-title: Biochem Pharmacol – volume: 7 year: 2021 ident: bb0335 article-title: Geographical separation and ethnic origin influence the human gut microbial composition: a meta-analysis from a Malaysian perspective publication-title: Microb Genomics – volume: 132 start-page: 1135 year: 2019 end-page: 1138 ident: bb0400 article-title: Facing a new challenge: the adverse effects of antibiotics on gut microbiota and host immunity publication-title: Chin Med J (Engl) – volume: 1998 start-page: 777 year: 1998 end-page: 803 ident: bb0250 article-title: Pharmacology of irinotecan publication-title: Drugs Today (Barc) – reference: (accessed 1.22.22). – volume: 1 start-page: 143 year: 1971 end-page: 156 ident: bb0255 article-title: The Role of the Gut Flora in the Metabolism of Prontosil and Neoprontosil in the Rat publication-title: Xenobiotica – volume: 12 year: 2021 ident: bb0380 article-title: Shared Environment and Genetics Shape the Gut Microbiome after Infant Adoption publication-title: MBio – volume: 43 start-page: 1499 year: 2015 end-page: 1504 ident: bb0200 article-title: Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry? publication-title: Drug Metab Dispos – volume: 2019 start-page: 7395127 year: 2019 ident: bb0435 article-title: Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent Clostridium difficile Infection: A Retrospective Cohort Study publication-title: Int J Microbiol – volume: 457 start-page: 480 year: 2009 end-page: 484 ident: bb0360 article-title: A core gut microbiome in obese and lean twins publication-title: Nature – volume: 486 start-page: 222 year: 2012 end-page: 227 ident: bb0330 article-title: Human gut microbiome viewed across age and geography publication-title: Nature – volume: 21 start-page: 1 year: 2017 end-page: 20 ident: bb0075 article-title: Drug metabolism in the liver publication-title: Clin Liver Dis – year: 2021 ident: bb0040 article-title: Biochemistry, Biotransformation, StatPearls [Internet] – volume: 14 year: 2019 ident: bb0305 article-title: Gut microbiome diversity is associated with sleep physiology in humans publication-title: PLoS One – volume: 9 start-page: 215 year: 2010 end-page: 236 ident: bb0150 article-title: Membrane transporters in drug development publication-title: Nat Rev Drug Discov – volume: 58 start-page: S164 year: 2018 end-page: S179 ident: bb0465 article-title: Probiotics in Disease Prevention and Treatment publication-title: J Clin Pharmacol – volume: 41 start-page: 647 year: 1991 end-page: 664 ident: bb0260 article-title: Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease publication-title: Drugs – volume: 12 start-page: 1752605 year: 2020 ident: bb0340 article-title: Metagenomics reveals impact of geography and acute diarrheal disease on the Central Indian human gut microbiome publication-title: Gut Microbes – volume: 66 start-page: 569 year: 2017 end-page: 580 ident: bb0430 article-title: European consensus conference on faecal microbiota transplantation in clinical practice publication-title: Gut – volume: 56 start-page: 945 year: 1987 end-page: 993 ident: bb0070 article-title: P450 genes: structure, evolution, and regulation publication-title: Annu Rev Biochem – volume: 179 start-page: 204 year: 2017 end-page: 222 ident: bb0180 article-title: Gut Microbiome Interactions with Drug Metabolism, Efficacy and Toxicity publication-title: Transl Res – year: 2021 ident: bb0415 article-title: Your life after C. diff can go back to normal. [WWW Document] publication-title: Cent Dis Control Prev – volume: 18 start-page: 690 year: 2017 end-page: 699 ident: bb0370 article-title: Human genetic variation and the gut microbiome in disease publication-title: Nat Rev Genet – volume: 48 start-page: 331 year: 2016 end-page: 341 ident: bb0155 article-title: Effects of Soy Containing Diet and Isoflavones on Cytochrome P450 Enzyme Expression and Activity publication-title: Drug Metab Rev – volume: 16 year: 2021 ident: bb0235 article-title: Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression publication-title: PLoS One – volume: 281 start-page: 408 year: 1969 end-page: 412 ident: bb0270 article-title: Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial publication-title: N Engl J Med – volume: 42 start-page: 1349 year: 2014 end-page: 1356 ident: bb0145 article-title: Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis publication-title: Drug Metab Dispos – volume: 15 start-page: 1183 year: 2009 end-page: 1189 ident: bb0105 article-title: Low counts of Faecalibacterium prausnitzii in colitis microbiota publication-title: Inflamm Bowel Dis – volume: 16 start-page: 567 year: 2018 end-page: 576 ident: bb0225 article-title: Keystone taxa as drivers of microbiome structure and functioning publication-title: Nat Rev Microbiol – volume: 164 start-page: 337 year: 2016 end-page: 340 ident: bb0185 article-title: Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans publication-title: Cell – volume: 14 start-page: 134 year: 2016 ident: bb0440 article-title: Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection publication-title: BMC Med – volume: 12 start-page: 31 year: 2016 end-page: 40 ident: bb0205 article-title: The influence of gut microbiota on drug metabolism and toxicity publication-title: Expert Opin Drug Metab Toxicol – volume: 555 start-page: 210 year: 2018 end-page: 215 ident: bb0375 article-title: Environment dominates over host genetics in shaping human gut microbiota publication-title: Nature – volume: 60 start-page: 971 year: 2021 end-page: 984 ident: bb0245 article-title: Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability publication-title: Clin Pharmacokinet – reference: Antimicrobial resistance [WWW Document], n.d. URL – volume: 63 start-page: 101 year: 2019 end-page: 108 ident: bb0115 article-title: Gut microbiome and type 2 diabetes: where we are and where to go? publication-title: J Nutr Biochem – volume: 7 start-page: 35 year: 1997 end-page: 43 ident: bb0240 article-title: Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil publication-title: Pharmacogenetics – volume: 10 start-page: 19 year: 2020 end-page: 32 ident: bb0280 article-title: The gut microbiome: an orchestrator of xenobiotic metabolism publication-title: Acta Pharm Sin B – volume: 2008 start-page: 1 year: 2008 end-page: 9 ident: bb0455 article-title: Probiotic Bacteria Influence the Composition and Function of the Intestinal Microbiota publication-title: Interdiscip Perspect Infect Dis – volume: 10 start-page: 20131037 year: 2014 ident: bb0325 article-title: Geographical variation of human gut microbial composition publication-title: Biol Lett – volume: 11 start-page: 1139 year: 2020 ident: bb0365 article-title: Comparison of Meconium Microbiome in Dizygotic and Monozygotic Twins Born by Caesarean Section (CS) publication-title: Front Microbiol – volume: 1 year: 2019 ident: bb0390 article-title: Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit publication-title: JAC-Antimicrob Resist – volume: 9 start-page: 1835 year: 2018 ident: bb0015 article-title: The Human Gut Microbiome – A Potential Controller of Wellness and Disease publication-title: Front Microbiol – volume: 318 start-page: G84 year: 2020 end-page: G98 ident: bb0055 article-title: Role of gut microbiota in liver disease publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 40 start-page: 1366 year: 2012 end-page: 1379 ident: bb0290 article-title: Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice publication-title: Drug Metab Dispos – reference: WHO 2021 New report calls for urgent action to avert antimicrobial resistance crisis [WWW Document], URL https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis (accessed 1.15.22). – volume: 11 start-page: 300 year: 2021 ident: bb0460 article-title: Probiotics-induced changes in gut microbial composition and its effects on cognitive performance after stress: exploratory analyses publication-title: Transl Psychiatry – volume: 107 start-page: 1755 year: 2012 ident: bb0410 article-title: Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation? publication-title: Off J Am Coll Gastroenterol ACG – volume: 503 start-page: 90 year: 2020 end-page: 98 ident: bb0080 article-title: Fecal microbiota transplantation in disease therapy publication-title: Clin Chim Acta Int J Clin Chem – volume: 123 start-page: 1127 year: 2020 end-page: 1137 ident: bb0110 article-title: Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism publication-title: Br J Nutr – volume: 2017 start-page: 3831972 year: 2017 ident: bb0310 article-title: Exercise Modifies the Gut Microbiota with Positive Health Effects publication-title: Oxid Med Cell Longev – reference: (accessed 1.15.22). – volume: 102 start-page: 805 year: 2018 end-page: 818 ident: bb0475 article-title: Antimicrobial Stewardship and Antimicrobial Resistance publication-title: Med Clin North Am – volume: 29 start-page: 479 year: 2014 end-page: 481 ident: bb0010 article-title: 20 Things You Didn't Know About the Human Gut Microbiome publication-title: J Cardiovasc Nurs – volume: 179 year: 2016 ident: bb0175 article-title: Gut Microbiome Interactions with Drug Metabolism publication-title: Efficacy and Toxicity Transl Res – volume: 109 start-page: 1065 year: 2014 end-page: 1071 ident: bb0450 article-title: Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients publication-title: Am J Gastroenterol – reference: . URL – volume: 44 start-page: 209 year: 1991 end-page: 214 ident: bb0265 article-title: Involvement of the intestinal microflora in nitrazepam-induced teratogenicity in rats and its relationship to nitroreduction publication-title: Teratology – volume: 21 start-page: 334 year: 2013 end-page: 341 ident: bb0135 article-title: The emerging world of the fungal microbiome publication-title: Trends Microbiol – volume: 12 start-page: 3903 year: 2019 end-page: 3910 ident: bb0470 article-title: Antimicrobial Resistance: Implications and Costs publication-title: Infect Drug Resist – volume: 18 start-page: 94 year: 2021 end-page: 101 ident: bb0060 article-title: Emulating the gut–liver axis: Dissecting the microbiome's effect on drug metabolism using multiorgan-on-chip models publication-title: Curr Opin Endocr Metab Res – volume: 15 start-page: 307 year: 2021 end-page: 315 ident: bb0035 article-title: Gut Microbiota-driven Drug Metabolism in Inflammatory Bowel Disease publication-title: J Crohns Colitis – volume: 51 year: 2020 ident: bb0120 article-title: Role of gut microbiota in type 2 diabetes pathophysiology publication-title: EBioMedicine – volume: 102 start-page: 508 year: 2021 end-page: 515 ident: bb0100 article-title: Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer publication-title: Digestion – volume: 24 start-page: 392 year: 2018 end-page: 400 ident: bb0020 article-title: Current understanding of the human microbiome publication-title: Nat Med – volume: 8 start-page: 845 year: 2017 ident: bb0125 article-title: The gut microbiome in atherosclerotic cardiovascular disease publication-title: Nat Commun – volume: 8 start-page: 1162 year: 2017 ident: bb0320 article-title: Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity publication-title: Front Microbiol – volume: 10 start-page: 98 year: 2019 ident: bb0315 article-title: Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies publication-title: Front Genet – volume: 5 start-page: 233 year: 2014 end-page: 238 ident: bb0220 article-title: Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics publication-title: Gut Microbes – volume: 2018 start-page: 1394379 year: 2018 ident: bb0445 article-title: A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients publication-title: Can J Gastroenterol Hepatol – volume: 160 year: 2016 ident: bb0275 article-title: Human gut microbiota plays a role in the metabolism of drugs publication-title: Biomed Pap – volume: 12 start-page: 7492 year: 2006 end-page: 7497 ident: bb0160 article-title: Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer publication-title: Clin Cancer Res – volume: 2 start-page: 875 year: 2006 end-page: 894 ident: bb0065 article-title: Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction publication-title: Expert Opin Drug Metab Toxicol – volume: 6 start-page: 47 year: 2019 ident: bb0300 article-title: The Effects of Vegetarian and Vegan Diets on Gut Microbiota publication-title: Front Nutr – volume: 363 start-page: 1 year: 2008 end-page: 25 ident: bb0190 article-title: The gastrointestinal microbiota as a site for the biotransformation of drugs publication-title: Int J Pharm – reference: PubChem, n.d. Chloramphenicol [WWW Document]. URL – volume: 570 start-page: 462 year: 2019 end-page: 467 ident: bb0285 article-title: Mapping human microbiome drug metabolism by gut bacteria and their genes publication-title: Nature – volume: 41 start-page: 344 year: 2009 end-page: 390 ident: bb0025 article-title: Drug metabolism and pharmacokinetics publication-title: Drug Metab Rev – volume: 7 start-page: 14 year: 2019 ident: bb0090 article-title: What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases publication-title: Microorganisms – volume: 181 start-page: 1661 year: 2020 end-page: 1679 ident: bb0030 article-title: Personalized Mapping of Drug Metabolism by the Human Gut Microbiome publication-title: Cell – reference: Genome-Wide Association Studies Fact Sheet [WWW Document], n.d. – volume: 48 start-page: 693 year: 2014 end-page: 702 ident: bb0425 article-title: Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review publication-title: J Clin Gastroenterol – reference: Cancer [WWW Document], 2021 URL – volume: 15 year: 2020 ident: bb0210 article-title: An in vitro evaluation of the effects of different statins on the structure and function of human gut bacterial community publication-title: PLoS One – volume: 44 start-page: 262 year: 2016 end-page: 274 ident: bb0295 article-title: Regulation of Hepatic Drug Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics publication-title: Drug Metab Dispos – year: 2018 ident: bb0345 article-title: Gut microbiota features of the geographically diverse Indian population (preprint) publication-title: Microbiology – volume: 2 start-page: 1183 year: 2008 end-page: 1193 ident: bb0130 article-title: Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces publication-title: ISME J – volume: 61 start-page: 1303 year: 2009 end-page: 1307 ident: bb0230 article-title: In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability? publication-title: J Pharm Pharmacol – volume: 1 start-page: 107 year: 2000 end-page: 132 ident: bb0050 article-title: Drug-Metabolizing Enzymes: Mechanisms and Functions publication-title: Curr Drug Metab – volume: 13 start-page: 1870402 year: 2021 ident: bb0405 article-title: Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis publication-title: Gut Microbes – volume: 7 year: 2016 ident: bb0355 article-title: Correlations of Host Genetics and Gut Microbiome Composition publication-title: Front Microbiol – reference: (accessed 1.23.22). – volume: 21 start-page: 8787 year: 2015 end-page: 8803 ident: bb0085 article-title: Role of the normal gut microbiota publication-title: World J Gastroenterol – volume: 4 start-page: 59 year: 2009 ident: bb0140 article-title: The Cytochrome P450 Homepage publication-title: Hum Genomics – volume: 12 year: 2017 ident: bb0420 article-title: The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact publication-title: PLoS One |
| SSID | ssj0066138 |
| Score | 2.3304703 |
| Snippet | This chapter focuses on intestinal microbiota and its effect on drug metabolism. Here, we discussed about different drugs which are metabolized either by some... |
| SourceID | proquest elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | 207 |
| SubjectTerms | Drug metabolism pathways Gut microbiota dysbiosis Hepatic drug metabolism Infectious diseases Intestinal disorders Intestinal microbiota Keystone species Keystone species associated with drug metabolism Metabolic disorders |
| Title | Hepatic drug metabolism and gut microbiome |
| URI | https://dx.doi.org/10.1016/bs.pmbts.2022.07.005 https://www.proquest.com/docview/2727642028 |
| Volume | 191 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9MwGLZQd-GCgIEYXzIS4kCUkThOnB6raajaBELQid0iO7ZHRZtOnXOAX8_rr2SFHcYuURpFqePHej-c530fhN4qWEMcPHuqtaApLSqRimldpZK3OVEaDODUFgp_-lzNz-jJeXkeNdtDdYkRh-3vG-tK7oIqXANcbZXsfyA7PBQuwDngC0dAGI63wniuLl3DVbntL6wWNAC6iqIXF71J1kvfZmm3IcEXS8myBm7ZJeuojptc78ZkrANbxW3C4CQHaNSP7cY4eaJkwS3ba9zV7lfLn57rI5bbxNG3r28rkDH9HCpddoiYec1YmudedmSwnF5oa2eJBDvopWyDSyW-_vsfa-03DsTV4eVaGNs7nRDXSTUrR-80cAa_2SHYERBLA3M9YPcI5AZkgvZmp1-_n0YHDBGHEzAfhhwrJvPqw03_tROG_OWQXZSxeIgehPQAzzzWj9A91T1G-7OOm836F36HHWHXAbWP3gf4sYUfj_BjgBAD_HiE_wk6-3i8OJqnQfoiVTBgkwqqdc2kYhLeAqJckU0l0VxTyWibZ0U7pawqNROSlbrOSk21LEXR6kKDkda8eIom3aZTzxAGIy4VF6KuBaN1kfNCSG0zAS5UWVB6gFh8_SYsKB9NNQBTE0mA4qpxE9fYiWsyS1ooD9CbOFsNGCX7pYl3atPDTRAVQ2ILsevzOz_9Bbpvf_ntrpdoYra9egUBoBGvA-B_AL_yX-g |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatic+drug+metabolism+and+gut+microbiome&rft.jtitle=Progress+in+molecular+biology+and+translational+science&rft.au=Mehrotra%2C+Tanshi&rft.au=Maulik%2C+Subir+Kumar&rft.date=2022&rft.pub=Elsevier+Inc&rft.issn=1877-1173&rft.volume=191&rft.issue=1&rft.spage=207&rft.epage=228&rft_id=info:doi/10.1016%2Fbs.pmbts.2022.07.005&rft.externalDocID=S1877117322001004 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1877-1173&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1877-1173&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1877-1173&client=summon |